Observational studyBiomolecules & biomedicine2024
Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina.
Nermin Salkić et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.